Quantitative Fecal Lactoferrinas a Biomarker for Severe Clostridium difficile Infection in Hospitalized Patients

Journal Title: Journal of Geriatrics and Palliative Care - Year 2014, Vol 2, Issue 1

Abstract

Background: The incidence and severity of Clostridium difficile infection (CDI) have increased over the past decade, especially among hospitalized patients. In this study, we determined the value of published criteria for severe CDI in predicting 3 month mortality, as well as the utility of fecal lactoferrin as a biomarker for severe CDI. Methods: Pilot Year 1 of IRB approved (HSR-IRB# 13630) prospective cohort study of hospitalized patients with CDI at US academic medical center (10/08-4/10). Medical records of hospitalized patients with clinically diagnosed CDI, via toxin assay, were evaluated to objectively define severe CDI based on current guidelines. A stool sample from CDI diagnosis was analyzed for amount of fecal lactoferrin (IBD-SCAN, TechLab, Inc.). Data was analyzed using SPSS for student’s t-test and chi-squared, significance p ≤ 0.05. Results: 79 subjects consented and enrolled, mean age was 64 years (standard deviation, sd, 17.2), 48 (61%) female, and average Charlson co-morbidity score was 5.8 (sd 3.8). Subjects with severe CDI were 5 times more likely to die within 3 months of diagnosis (Odds Ratio 5.66 (95% Confidence Interval 2.03-15.79), p=0.001) and had significantly more fecal lactoferrin (580.0 (sd 989.0) vs. 181.7 (sd 244.2) μg/mL, p=0.018), compared to those that did not meet severe CDI criteria. Conclusion:In this pilot study, subjects who meet defined criteria for severe CDI had higher mortality and more intestinal inflammation. These preliminary results were, however, underpowered to show a direct association of lactoferrin with mortality. Larger cohort studies are needed to optimize a criterion for severe CDI and evaluate a direct association of lactoferrin and mortality in hospitalized patients with CDI.

Authors and Affiliations

Laurie Archbald-Pannone

Keywords

Related Articles

Cancer and Aging; Preparing for Silver Tsunami

Growing number of older adults is one the most significant sociodemographic changes in the United States in the next few decades. Advancing age is associated with increased incidence of cancer and other age-related healt...

Ageism: Discrimination that Must Disappear.

Introduction: Ageism or old age is a very old concept and refers to negative stereotypes and prejudicial attitudes toward old age and how these are reflected in psychological and social problems. Discussion: Ageism has b...

Quantitative Fecal Lactoferrinas a Biomarker for Severe Clostridium difficile Infection in Hospitalized Patients

Background: The incidence and severity of Clostridium difficile infection (CDI) have increased over the past decade, especially among hospitalized patients. In this study, we determined the value of published criteria fo...

Dying in Nursing Homes and Long Term Care: A Mini-Review

Little is known about end-of-life conditions in Long Term Care (LTC) facilities. Comparatively, palliative care has expanded considerably into the Nursing Home (NH) setting in recent years: U. S. NH-hospice residents has...

Epidemiology of Physical Function Impairment in Global Chinese Aging Population: A Systematic Review

Background: Physical function is a cornerstone of geriatric medicine. Impairment in physical function may threaten one’s ability to live independently and is associated with multiple negative health outcomes. Although Ch...

Download PDF file
  • EP ID EP203937
  • DOI 10.13188/2373-1133.1000006
  • Views 90
  • Downloads 0

How To Cite

Laurie Archbald-Pannone (2014). Quantitative Fecal Lactoferrinas a Biomarker for Severe Clostridium difficile Infection in Hospitalized Patients. Journal of Geriatrics and Palliative Care, 2(1), 1-3. https://europub.co.uk/articles/-A-203937